Since 2017, The Biocodex Microbiota Foundation rewards national research initiatives which aim to understand the interaction between microbiota and different pathologies. By promoting scientists from around the world at a key moment in their career, the grant seeks to motivate researchers to continue to explore the world of gut microbiota.
The annual call for proposals is carried out in countries where Biocodex has a subsidiary presence. An independent local scientific committee – made up of individuals recognized for their expertise in the microbiota field – gathers all proposals and selects the winning project to be granted.
Biocodex Microbiota Foundation in collaboration with Biocodex Microbiota Institute put national winners in the spotlight through testimonies and interviews!
Since 2017, The Biocodex Microbiota Foundation rewards national research initiatives which aim to understand the interaction between microbiota and different pathologies. By promoting scientists from around the world at a key moment in their career, the grant seeks to motivate researchers.
Granted projects
2025
mi-LK - Impact des miRNA du lait maternel sur la composition et la santé du microbiote intestinal du nourrisson
2024
Fecal microbiome and association with clinical outcome and the tumor microenvironment in patients receiving pre-operative pembrolizumab with radiation therapy in early-stage triple-negative breast cancer
AGEWISE: Unravelling the gut-hormone axis in Women's Aging
Innovative Neuroprotection: The Impact of Extracellular Vesicles from Commensal Bifidobacterium Strains on Blood-Brain Barrier Protection in Inflammation
Multi-omic integration for improving the risk estimation of type 2 diabetes
Rôle du microbiote intestinal dans les troubles du mésusage de l’alcool
Painful autoantibody cross-reactivity with the gut microbiome in fibromyalgia
Towards a better understanding of a Gut-Vagina Axis by investigating the effects of Ramadan fasting on Gut and Vaginal Microbial Communities
2023
Time restricted eating modulates gut microbiome and metabolome to improve immunotherapy outcomes in African American (AA) patients with Head and Neck squamous cell cancer (HNSCC)